IL157792A0 - Use of thiolutin dioxide and its derivatives in the manufacture of a medicament, and a process for the preparation thereof - Google Patents

Use of thiolutin dioxide and its derivatives in the manufacture of a medicament, and a process for the preparation thereof

Info

Publication number
IL157792A0
IL157792A0 IL15779202A IL15779202A IL157792A0 IL 157792 A0 IL157792 A0 IL 157792A0 IL 15779202 A IL15779202 A IL 15779202A IL 15779202 A IL15779202 A IL 15779202A IL 157792 A0 IL157792 A0 IL 157792A0
Authority
IL
Israel
Prior art keywords
medicament
derivatives
manufacture
preparation
thiolutin dioxide
Prior art date
Application number
IL15779202A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL157792A0 publication Critical patent/IL157792A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL15779202A 2001-03-09 2002-02-23 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament, and a process for the preparation thereof IL157792A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01105959A EP1238668A1 (en) 2001-03-09 2001-03-09 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of CNS disorders and a process for the preparation thereof
PCT/EP2002/001915 WO2002072089A2 (en) 2001-03-09 2002-02-23 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof

Publications (1)

Publication Number Publication Date
IL157792A0 true IL157792A0 (en) 2004-03-28

Family

ID=8176735

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15779202A IL157792A0 (en) 2001-03-09 2002-02-23 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament, and a process for the preparation thereof

Country Status (24)

Country Link
US (2) US20020193418A1 (ko)
EP (2) EP1238668A1 (ko)
JP (1) JP2004521927A (ko)
KR (1) KR20040025902A (ko)
CN (1) CN1279906C (ko)
AT (1) ATE333276T1 (ko)
AU (1) AU2002250997B2 (ko)
BG (1) BG108161A (ko)
BR (1) BR0207884A (ko)
CA (1) CA2439853A1 (ko)
CZ (1) CZ20032427A3 (ko)
DE (1) DE60213219D1 (ko)
EE (1) EE200300430A (ko)
HR (1) HRP20030714A2 (ko)
IL (1) IL157792A0 (ko)
MX (1) MXPA03007551A (ko)
NO (1) NO20033964D0 (ko)
NZ (1) NZ528071A (ko)
PL (1) PL363374A1 (ko)
RU (1) RU2003129889A (ko)
SK (1) SK11202003A3 (ko)
WO (1) WO2002072089A2 (ko)
YU (1) YU68403A (ko)
ZA (1) ZA200306474B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108371661B (zh) * 2018-01-19 2019-03-19 中国人民解放军军事科学院军事医学研究院 硫藤黄菌素在抑制nlrp3炎症小体活化中的应用
CN113209088B (zh) * 2021-03-11 2022-03-22 中国人民解放军军事科学院军事医学研究院 硫藤黄菌素在保护非酒精性脂肪性肝炎中的应用
CN115261422A (zh) * 2022-06-30 2022-11-01 塔里木大学 一种新物种来源硫藤黄菌素的制备方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2217957A1 (en) * 1995-04-11 1996-10-17 Genhui Chen Xenorxides with antibacterial and antimycotic properties
CA2212237A1 (en) * 1997-09-05 1999-03-05 John M. Webster Novel antineoplastic agents

Also Published As

Publication number Publication date
CZ20032427A3 (cs) 2004-01-14
CN1279906C (zh) 2006-10-18
EP1372640B1 (en) 2006-07-19
EP1238668A1 (en) 2002-09-11
CA2439853A1 (en) 2002-09-19
RU2003129889A (ru) 2005-03-10
US20050059725A1 (en) 2005-03-17
BG108161A (en) 2004-09-30
DE60213219D1 (de) 2006-08-31
WO2002072089A2 (en) 2002-09-19
EE200300430A (et) 2003-12-15
EP1372640A2 (en) 2004-01-02
NO20033964L (no) 2003-09-08
US20020193418A1 (en) 2002-12-19
WO2002072089A3 (en) 2002-11-14
NO20033964D0 (no) 2003-09-08
CN1501800A (zh) 2004-06-02
SK11202003A3 (sk) 2004-02-03
YU68403A (sh) 2006-08-17
NZ528071A (en) 2005-02-25
BR0207884A (pt) 2004-07-27
HRP20030714A2 (en) 2005-04-30
AU2002250997B2 (en) 2006-03-09
ZA200306474B (en) 2004-04-29
PL363374A1 (en) 2004-11-15
KR20040025902A (ko) 2004-03-26
JP2004521927A (ja) 2004-07-22
MXPA03007551A (es) 2003-12-04
ATE333276T1 (de) 2006-08-15

Similar Documents

Publication Publication Date Title
IL192078A0 (en) Recombinant ??-l-iduronidase,methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
TNSN04082A1 (en) N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
IL152073A0 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
MXPA04002405A (es) Derivados de fenetanolamina para tratamiento de enfermedades respiratorias.
NZ521681A (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
IL158738A0 (en) Novel use of 2-phenyl-substituted imidazotriazinones
DE50305587D1 (en) 2-heteroarylcarbonsäureamide
WO2003078430A8 (de) Essig- und propionsäureamide
HRP20030714A2 (en) Use of thiolutin dioxide and its derivatives in the manufacture of a medicament, and a process for the preparation thereof
HUP0303926A3 (en) Process for the production of l-amino acids by fermentation using coryneform bacteria
AU2002325942A1 (en) Process for the production of l-amino acids using coryneform bacteria
EP1736468A3 (en) Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation
RS20060263A (en) Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer
BG108151A (en) Caloporoside derivatives, methods for the production thereof and their use
MXPA03002047A (es) Fenilciclohexanocarboxamidas substituidas y su uso.
MXPA04001951A (es) Coniosulfuros y sus derivados, procesos para prepararlos, y su uso como farmaceuticos.
AU2358301A (en) Glyoxyl acid amides